000 | 01929 a2200553 4500 | ||
---|---|---|---|
005 | 20250513104956.0 | ||
264 | 0 | _c19970109 | |
008 | 199701s 0 0 eng d | ||
022 | _a0270-9139 | ||
024 | 7 |
_a10.1002/hep.510240607 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aHsu, H Y | |
245 | 0 | 0 |
_aHumoral and cellular immune responses to hepatitis B vaccination in hepatitis B surface antigen-carrier children who cleared serum-hepatitis B surface antigen. _h[electronic resource] |
260 |
_bHepatology (Baltimore, Md.) _cDec 1996 |
||
300 |
_a1355-60 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAntibody Formation |
650 | 0 | 4 |
_aCD8-Positive T-Lymphocytes _ximmunology |
650 | 0 | 4 |
_aCarrier State _ximmunology |
650 | 0 | 4 | _aCells, Cultured |
650 | 0 | 4 | _aChild |
650 | 0 | 4 |
_aCytokines _xbiosynthesis |
650 | 0 | 4 |
_aDNA, Viral _xblood |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aHLA-DQ Antigens _xblood |
650 | 0 | 4 |
_aHLA-DR Antigens _xblood |
650 | 0 | 4 |
_aHepatitis B _ximmunology |
650 | 0 | 4 |
_aHepatitis B Antibodies _xbiosynthesis |
650 | 0 | 4 |
_aHepatitis B Surface Antigens _xadministration & dosage |
650 | 0 | 4 | _aHepatitis B Vaccines |
650 | 0 | 4 |
_aHepatitis B virus _xisolation & purification |
650 | 0 | 4 | _aHistocompatibility Testing |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aImmunity, Cellular |
650 | 0 | 4 | _aImmunization Schedule |
650 | 0 | 4 |
_aInterferon-gamma _xbiosynthesis |
650 | 0 | 4 |
_aInterleukin-4 _xbiosynthesis |
650 | 0 | 4 | _aLymphocyte Activation |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aPolymerase Chain Reaction |
700 | 1 | _aChang, M H | |
700 | 1 | _aHsieh, R P | |
700 | 1 | _aNi, Y H | |
700 | 1 | _aChi, W K | |
773 | 0 |
_tHepatology (Baltimore, Md.) _gvol. 24 _gno. 6 _gp. 1355-60 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1002/hep.510240607 _zAvailable from publisher's website |
999 |
_c8930563 _d8930563 |